Research Article

A PROGRESSIVE EMBRYONAL RHABDOMYOSARCOMA OF THE UTERINE CERVIX WITH RIGHT BREAST LUMP IN A 43-YEAR-OLD ADULT: A CASE REPORT

Amina I Dansani1*, Tajudeen A. Olasinde2, Olabisi T. Ojo3, Aisha Mustapha4, Shehu Abdullahi5, Shehu Salihu Umar6
1 Department of Radiation and Clinical Oncology, Federal Teaching Hospital Katsina, Katsina State, Nigeria
2 Department of Radiation and Clinical Oncology, Ahmadu Bello University Teaching Hospital Zaria, Kaduna State, Nigeria.
3 Department of Radiation Oncology, University of Ibadan/University College Hospital, Ibadan.
4 Department of Obstetrics and Gynecology, Ahmadu Bello University, Zaria, Kaduna State, Nigeria
5 Department of Pathology, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria.
6 Department of Radiology, Ahmadu Bello University Zaria, Kaduna State, Nigeria
* Corresponding author: meenadansani@gmail.com
Published: Jul, 2025
DOI: 10.67579/njo.2025.xr23ody7
Pages: 313-320
Views: 284
Downloads: 169
Cited by: 1

Abstract

Introduction: Embryonal Rhabdomyosarcoma is an uncommon type of sarcoma often seen in pediatric and adolescent patients, with the botryoid subtype being the most common. The incidence of this disease in adult females is 0.4% to 1% with the affected age group being patients in the third to fourth decade of life. It is rare in patients above 40 years in Nigeria.


Case Presentation: We describe the case of a 43-year-old, para 4+1, 4 alive, premenopausal female health worker, with an ECOG performance status of 1, who presented with a protruding cauliflower, exophytic cervical polyp extending to the lower one-third of the vagina of eight months duration. Post-polypectomy histology revealed a huge, highly vascularized mass, with high histologic grade, and some cartilaginous components. Based on financial limitations and out-of-pocket payments, the patient could not afford standard concurrent chemo-radiation post-surgery. Adjuvant chemotherapy with intravenous (IV) Vincristine 2mg Day 1, Doxorubicin 100mg Day 1, and Cyclophosphamide 1000mg D1 (VAC) regimen, 3 weekly for 6 courses, was offered to the patient. However, a partial response after the third course was noticed, with an incidental finding of a right breast mass noted. A modified regimen with the addition of IV Dacarbazine 1500mg on Day 1 was given due to poor response and tumour recurrence. Total abdominal hysterectomy (TAH) with bilateral salpingo-oophorectomy (BSO) was done, and immunohistochemistry for Desmin was strongly positive. The patient's performance status remains the same while further evaluation of the right breast is being carried out. She has been counseled to undergo radiotherapy as soon as possible. We discuss the disease in general, pathologic features of the disease, epidemiology, presentation patterns with prognostic factors, management modalities with consideration of standard radiation therapy management, and outcomes.


Keywords

Polypectomy Cervical Polyp Sarcoma Radiotherapy Cervical embryonal rhabdomyosarcoma Nigeria

References

  1. Ibrahim U, Saqib A, Mohammad F, Ding J, Salman B, Collado FK, et al. Embryonal Rhabdomyosarcoma of the Cervix: A Rare Disease at an Uncommon Age. Cureus. 2017;9(11).
  2. Alkhaledi A, Hanafi I, Alsabe H, Chatty EM. Rhabdomyosarcoma of the uterus with multiple metastases in a post-menopausal woman. Oxford Medical Case Reports. 2019;2019(3).
  3. Razakanaivo M. Overview of embryonal rhabdomyosarcoma of cervix in women over 40-year-old. World Journal of Obstetrics and Gynecology. 2016;5(1):110.
  4. Pinto A, Kahn RM, Rosenberg AE, Slomovitz B, Quick CM, Whisman MK, et al. Uterine rhabdomyosarcoma in adults. Human Pathology. 2018; 74:122–8.
  5. Trihia HJ, Novkovic N, Provatas I, Mavrogiorgis A, Lianos E. Primary Alveolar Rhabdomyosarcoma of the Breast in an Adult: An Extremely Rare Case. Case Reports in Pathology. 2019; 2019:1–6.
  6. Aljehani AM, Abu-Zaid A, Alomar O, Jabrah EA, Alkushi A. Primary Uterine Rhabdomyosarcoma in a 54-Year-Old Postmenopausal Woman. Cureus. 2020.
  7. Treating Rhabdomyosarcoma [Internet]. American Cancer Society. American Cancer Society medical and editorial team; 2018 [cited 2018Jul16]. Available from: https://www.cancer.org/cancer/rhabdomyosarcoma/treating/radiation-therapy.html
  8. Bouchard-Fortier G, Kim RH, Allen L, Gupta A, May T. Fertility-sparing surgery for the management of young women with embryonal rhabdomyosarcoma of the cervix: A case series. Gynecologic Oncology Reports. 2016; 18:4–7.
  9. Jayi S, Bouguern H, Fdili FZ, Chaara H, Chbani L, Hafidi I, et al. Embryonal rhabdomyosarcoma of the cervix presenting as a cervical polyp in a 16-year-old adolescent: a case report. Journal of Medical Case Reports. 2014;8(1).
  10. Meseci E, Onculoglu C, Ince U, Teomete M, Eser SK, Demirkiran F. Embryonal rhabdomyosarcoma of the uterine cervix in a pregnant woman. Taiwanese Journal of Obstetrics and Gynecology. 2014;53(3):423–5.
  11. Apellaniz-Ruiz M, McCluggage WG, Foulkes WD. DICER1-associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: Pathology, molecular genetics, and indications for molecular testing. Genes, Chromosomes and Cancer. 2020;60(3):217–33.
  12. Khosla D, Sapkota S, Kapoor R, Kumar R, Sharma SC. Adult rhabdomyosarcoma: Clinical presentation, treatment, and outcome. Journal of Cancer Research and Therapeutics. 2015;11(4):830.
  13. Buckley SL; Tritz DM; Van Le L; Higgins R; Sevin BU; Ueland FR; et al. Lymph node metastases and prognosis in patients with stage IA2 cervical cancer [Internet]. Gynecologic oncology. U.S. National Library of Medicine; [cited 2021Apr1]. Available from: https://pubmed.ncbi.nlm.nih.gov/8898159/
  14. Bergsjø P, Kristiansen P. Treatment Method and Dose Distribution in Radiotherapy of Carcinoma of the Cervix. Acta Radiologica: Therapy, Physics, Biology. 1968;7(3):181–92.
  15. Cassady JR. Rhabdomyosarcoma. Radiation Therapy in Pediatric Oncology. 1994;281–304.
  16. Koukourakis GV, Kouloulias V, Zacharias G, Maravelis G, Papadimitriou C, Platoni K, et al. Embryonal rhabdomyosarcoma of the uterine cervix. Clinical and Translational Oncology. 2009;11(6):399–402.
  17. Kriseman ML, Wang W-L, Sullinger J, Schmeler KM, Ramirez PT, Herzog CE, et al. Rhabdomyosarcoma of the cervix in adult women and younger patients. Gynecologic Oncology. 2012;126(3):351–6.

Cited By (1)

Works that cite this article, via Crossref Cited-by.

  1. Adult cervical embryonal rhabdomyosarcoma: a literature review of 41 adult cases with an illustrative aggressive case . Gynecologic Oncology Reports (2026) . https://doi.org/10.1016/j.gore.2026.102169
How to Cite

Dansani, A. I., Olasinde, T. A., Ojo, O. T., Mustapha, A., Abdullahi, S., & Umar, S. S. (2025). A PROGRESSIVE EMBRYONAL RHABDOMYOSARCOMA OF THE UTERINE CERVIX WITH RIGHT BREAST LUMP IN A 43-YEAR-OLD ADULT: A CASE REPORT. Nigerian Journal of Oncology, 1(2), 313-320. https://doi.org/10.67579/njo.2025.xr23ody7

A. I. Dansani, T. A. Olasinde, O. T. Ojo, A. Mustapha, S. Abdullahi, and S. S. Umar, "A PROGRESSIVE EMBRYONAL RHABDOMYOSARCOMA OF THE UTERINE CERVIX WITH RIGHT BREAST LUMP IN A 43-YEAR-OLD ADULT: A CASE REPORT," Nigerian Journal of Oncology, vol. 1, no. 2, pp. 313-320, July 2025. doi: 10.67579/njo.2025.xr23ody7

Share this article:
Facebook X / Twitter LinkedIn
Download PDF View Full Text (PDF) Back to Articles